Accendra Health, Inc.
$3.52
▲
6.05%
2026-04-21 05:02:01
www.accendrahealth.com
NYQ: ACH
Explore Accendra Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$270.97 M
Current Price
$3.52
52W High / Low
$9.55 / $1.84
Stock P/E
—
Book Value
$-6.04
Dividend Yield
—
ROCE
14.74%
ROE
-1.64%
Face Value
—
EPS
$-1.34
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Distribution
Employees
6,500
Beta
1.26
Debt / Equity
-4.6
Current Ratio
0.58
Quick Ratio
0.5
Forward P/E
2.7
Price / Sales
0.08
Enterprise Value
$2.1 B
EV / EBITDA
5.81
EV / Revenue
0.76
Rating
Hold
Target Price
$3.25
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cencora, Inc. | $310.27 | — | $13.74 B | 0.73% | 20.96% | 1.33% | $377.54 / $271 | $9.81 |
| 2. | Cardinal Health, Inc. | $202.95 | 29.15 | $47.74 B | 0.95% | 16.32% | -52.09% | $233.6 / $129.52 | $-12.22 |
| 3. | Henry Schein, Inc. | $78.73 | 24.1 | $9.06 B | — | 9.49% | 8.7% | $89.29 / $61.95 | $28.03 |
| 4. | Cosmos Health Inc. | $0.38 | — | $20.65 M | — | -53.42% | -63.82% | $1.32 / $0.28 | $0.73 |
| 5. | Synergy CHC Corp. | $0.51 | — | $5.93 M | — | -93.25% | 62.08% | $4 / $0.42 | $-0.73 |
| 6. | Empro Group Inc. | $17.36 | — | $144.63 M | — | 39.59% | 66.26% | $18.14 / $2.55 | $1.02 |
| 7. | McKesson Corporation | $837.14 | 24.1 | $102.52 B | 0.38% | 35.58% | -162.92% | $999 / $637 | $-10.55 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 708.97 M | 697.26 M | 681.92 M | 2.63 B | 2.7 B | — |
| Operating Profit | 51.76 M | 56.36 M | 56.75 M | 61.02 M | 94.92 M | — |
| Net Profit | -56.33 M | -150.28 M | -869.06 M | -24.98 M | -296.12 M | — |
| EPS in Rs | -0.74 | -1.97 | -11.37 | -0.33 | -3.87 | -0.17 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.76 B | 2.68 B | 2.55 B | 9.96 B |
| Operating Profit | 221.74 M | 198.04 M | 215.36 M | 276.78 M |
| Net Profit | -1.1 B | -362.69 M | -41.3 M | 22.39 M |
| EPS in Rs | -14.4 | -4.74 | -0.54 | 0.29 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.45 B | 4.66 B | 5.09 B | 5.39 B |
| Total Liabilities | 2.91 B | 4.07 B | 4.17 B | 4.44 B |
| Equity | -460.98 M | 586.36 M | 924.17 M | 945.6 M |
| Current Assets | 547.87 M | 2.02 B | 2.1 B | 2.3 B |
| Current Liabilities | 947.08 M | 1.85 B | 1.89 B | 1.57 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -101.79 M | 161.5 M | 740.71 M | 325.01 M |
| Investing CF | 144.42 M | -116.53 M | -137.25 M | -1.8 B |
| Financing CF | 188.08 M | -267.6 M | -417.33 M | 1.5 B |
| Free CF | -303.12 M | -21.17 M | 562.18 M | 158.42 M |
| Capex | -201.32 M | -182.66 M | -178.53 M | -166.58 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 5% | -74.36% | — | — |
| Earnings Growth % | -778.15% | -284.47% | — | — |
| Profit Margin % | -13.53% | -1.62% | 0.22% | — |
| Operating Margin % | 7.39% | 8.44% | 2.78% | — |
| Gross Margin % | 47.77% | 47.68% | 18.35% | — |
| EBITDA Margin % | -1.53% | 13.41% | 3.7% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2021-12-14 | $0.003 |
| 2021-09-14 | $0.003 |
| 2021-06-14 | $0.003 |
Stock Splits
No stock split history available.